ME3 - malic enzyme 3 Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 525813
ME3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001075877.1 | NP_001069345.1 | NADP-dependent malic enzyme, mitochondrial |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
NADP-dependent malic enzyme, mitochondrial |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-159834 | Progerinin | Inhibitor | 99.74% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(77)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15648B | GSK-J4 | 99.45% | Unkown | |
| HY-100421 | CPI-455 | Inhibitor | 98.95% | Unkown |
| HY-101117 | EED226 | Inhibitor | 99.56% | Unkown |
| HY-12583 | A-366 | Inhibitor | 98.13% | Unkown |
| HY-15648F | GSK-J4 hydrochloride | Inhibitor | 99.01% | Unkown |
| HY-150190 | F5446 | 99.73% | Unkown | |
| HY-15648 | GSK-J1 | Inhibitor | 99.94% | Unkown |
| HY-120400 | KDM5-C70 | Inhibitor | 98.82% | Unkown |
| HY-N7404 | Nε,Nε,Nε-Trimethyllysine chloride | 99.14% | Unkown | |
| HY-16705 | BRD4770 | Inhibitor | 99.79% | Unkown |
| HY-119344 | MS37452 | Inhibitor | 99.81% | Unkown |
| HY-100014 | KDM5A-IN-1 | Inhibitor | 99.64% | Unkown |
| HY-153191 | EZH2-IN-15 | Inhibitor | 99.18% | Unkown |
| HY-148458 | EZH2-IN-14 | Inhibitor | 98.06% | Unkown |
| HY-100421A | CPI-455 hydrochloride | Inhibitor | 99.95% | Unkown |
| HY-138691A | JQKD82 trihydrochloride | Inhibitor | 99.89% | Unkown |
| HY-66026 | Fmoc-Lys(Me)3-OH Chloride | 98.60% | Unkown | |
| HY-N7404S | Nε,Nε,Nε-Trimethyllysine-d9 chloride | / | Unkown | |
| HY-125837A | MS31 trihydrochloride | Inhibitor | 98.0% | Unkown |
| HY-125292 | NV03 | Antagonist | 99.77% | Unkown |
| HY-158432 | GT-653 | Degrader | 99.84% | Unkown |
| HY-132896 | KDM4-IN-3 | Inhibitor | 99.36% | Unkown |
| HY-15648A | GSK-J2 | Control | 99.75% | Unkown |
| HY-150249 | GSK3735967 | Inhibitor | 99.34% | Unkown |
| HY-N0857 | Deoxyandrographolide | Activator | 98.0% | Unkown |
| HY-100764 | YUKA1 | Inhibitor | 99.15% | Unkown |
| HY-126327A | UNC4976 TFA | Antagonist | 95.59% | Unkown |
| HY-P2254 | H3K27(Me3) (15-34) | 96.97% | Unkown | |
| HY-P2255 | H3K4(Me) (1-20) | 99.87% | Unkown | |
| HY-W051391 | 1,4,7-Trimethyl-1,4,7-triazonane | 98.50% | Unkown | |
| HY-15648D | GSK-J1 lithium salt | Inhibitor | 98.33% | Unkown |
| HY-126327 | UNC4976 | Antagonist | / | Unkown |
| HY-125837 | MS31 | Inhibitor | / | Unkown |
| HY-120766 | NCDM-32B | Inhibitor | 97.0% | Unkown |
| HY-P10463A | ssK36 TFA | Inhibitor | 99.34% | Unkown |
| HY-P2257 | H3K4(Me3) (1-20) | 98.69% | Unkown | |
| HY-W100209 | 5Me3F4AP | Inhibitor | 99.55% | Unkown |
| HY-169061 | WQQ-345 | / | Unkown | |
| HY-121511 | EML631 | Inhibitor | / | Unkown |
| HY-122595 | EZH2-IN-1 | Inhibitor | / | Unkown |
| HY-122640 | NPD13668 | Inhibitor | / | Unkown |
| HY-138691 | JQKD82 | Inhibitor | / | Unkown |
| HY-143616 | EZH2-IN-7 | Inhibitor | / | Unkown |
| HY-150619 | KDM4-IN-4 | Inhibitor | / | Unkown |
| HY-154599 | 5-Me-3’-dU-2’-phosphoramidite | / | Unkown | |
| HY-156292 | IHMT-EZH2-426 | Inhibitor | / | Unkown |
| HY-15648G | GSK-J1 sodium | Inhibitor | / | Unkown |
| HY-15648I | GSK-J2 sodium | Inhibitor | / | Unkown |
| HY-162601 | D-01 | Inhibitor | / | Unkown |
| HY-168131 | PROTAC EZH2 Degrader-3 | / | Unkown | |
| HY-169375 | RSL3-4-Me | Control | / | Unkown |
| HY-171338 | Gallocatechin-3-O-(3″-O-methyl)-gallate | Inhibitor | / | Unkown |
| HY-174397 | EED-IN-3 | Inhibitor | / | Unkown |
| HY-178694 | DC-PRC2in-01 | Inhibitor | / | Unkown |
| HY-179446 | HP1-IN-2 | Inhibitor | / | Unkown |
| HY-179499 | PROTAC EZH2 Degrader-9 | / | Unkown | |
| HY-181089 | CBX2-IN-1 | Inhibitor | / | Unkown |
| HY-181413 | PROTAC EZH2 Degrader-44 | / | Unkown | |
| HY-181914 | UNC7242 | Antagonist | / | Unkown |
| HY-182365 | EED-IN-4 | Inhibitor | / | Unkown |
| HY-182366 | EED-IN-5 | Inhibitor | / | Unkown |
| HY-182448 | TDI-11904 | Inhibitor | / | Unkown |
| HY-182676 | DC541 | Inhibitor | / | Unkown |
| HY-183602 | FRC-303 | Inhibitor | / | Unkown |
| HY-183603 | FRC-222 | Inhibitor | / | Unkown |
| HY-184270 | YM1240 | / | Unkown | |
| HY-P10111A | Histone H3K9me3 (1-15) TFA | / | Unkown | |
| HY-P2252 | H3K27(Me) (15-34) | / | Unkown | |
| HY-P2253 | H3K27(Me2) (15-34) | / | Unkown | |
| HY-RS08272 | ME3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-106258 | Atilmotin | Agonist | / | Unkown |
| HY-138691B | JQKD82 dihydrochloride | Inhibitor | / | Unkown |
| HY-169919 | HDM-IN-1 | Inhibitor | / | Unkown |
| HY-182962 | 7-Methylguanosine 5-disphosphoimidazolide disodium | / | Unkown | |
| HY-P10463 | ssK36 | Inhibitor | / | Unkown |
| HY-RS19564 | Me3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26060 | Me3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |